[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS6219095A - Racemization of 2-oxo-oxazolidine-4-carboxylic acid - Google Patents

Racemization of 2-oxo-oxazolidine-4-carboxylic acid

Info

Publication number
JPS6219095A
JPS6219095A JP15715385A JP15715385A JPS6219095A JP S6219095 A JPS6219095 A JP S6219095A JP 15715385 A JP15715385 A JP 15715385A JP 15715385 A JP15715385 A JP 15715385A JP S6219095 A JPS6219095 A JP S6219095A
Authority
JP
Japan
Prior art keywords
oxo
carboxylic acid
oxazolidine
ooc
racemize
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15715385A
Other languages
Japanese (ja)
Inventor
Koji Kubota
浩二 久保田
Eiji Majima
馬島 英治
Kenzo Yokozeki
健三 横関
Kunisuke Izawa
井沢 邦輔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP15715385A priority Critical patent/JPS6219095A/en
Priority to DE8585309455T priority patent/DE3580463D1/en
Priority to EP85309455A priority patent/EP0187525B1/en
Publication of JPS6219095A publication Critical patent/JPS6219095A/en
Priority to US07/348,112 priority patent/US5036004A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PURPOSE:To obtain the L-isomer of the titled compound useful as a raw material for producing L-serine, etc., by racemizing the D-isomer, by reacting a treated material of a microorganism of the genus Rhizopus, etc., with an optically active 2-oxo-oxazoline-4-carboxylic acid to racemize the compound. CONSTITUTION:A treated material of a microorganism, having the ability to racemize 2-oxo-oxazolidine-4-carboxylic acid or a salt thereof and belonging to the genus Rhizopus, Curvularia, Ephelis or Talaromyces, e.g. Rhizopus batatas (FERM-P No.8344), is reacted with optically active 2-oxo-oxazolidine-4-carboxylic acid or a salt thereof to racemize the compound. Examples of the treated material of the microorganism to be used include a culture fluid, separated microbial cells or decomposition products, etc.

Description

【発明の詳細な説明】 〈産業上の利用分野〉 本発明は、2−オキソ−オキサゾリジン−4−カルボン
酸又はその塩(以下単にoocと略記する)を、生化学
的にラセミ化する方法に関する。OOCは化学合成で容
易にかつ大量に供給され得るもので、本物質がL−セリ
ンを生化学的に製造する際の出発物質となり得ることを
本発明者らは明らかにした (特願昭59−28133
9以ところでL−セリンは医薬品、食品添加物あるいは
化粧品の原料として重要なアミノ酸である。
Detailed Description of the Invention <Industrial Application Field> The present invention relates to a method for biochemically racemizing 2-oxo-oxazolidine-4-carboxylic acid or a salt thereof (hereinafter simply abbreviated as ooc). . The present inventors have clarified that OOC can be easily supplied in large quantities through chemical synthesis, and that this substance can be used as a starting material for the biochemical production of L-serine. -28133
9 L-serine is an important amino acid as a raw material for pharmaceuticals, food additives, and cosmetics.

〈従来の技術〉 OOCは化学合成法により容易にかつ安価に生産され得
るが、合成されるのは一般に光学不活性なりL一体であ
って、これにOOC加水分解酵素生産菌を作用させたと
しても、L一体のみしか基質となり得す、収率が低く<
、経済的ではない。従って、収率を向上させるためには
、D−00Cをラセミ化して、L一体に変換する工程が
必要である。
<Prior art> OOC can be easily and inexpensively produced by chemical synthesis, but what is synthesized is generally optically inactive or monolithic L, and when an OOC hydrolase-producing bacterium is allowed to act on it. However, only one L can be used as a substrate, and the yield is low.
, not economical. Therefore, in order to improve the yield, it is necessary to racemize D-00C and convert it into L integrally.

〈本発明が解決しようとする問題点〉 本発明が解決しようとする問題点は、化学合成で得られ
るDL一体のOOCのうち、L一体のOOCを加水分解
等によりL−セリンに変換した時に残存するD一体をラ
セミ化する事により有効に利用する事にある。
<Problems to be solved by the present invention> The problems to be solved by the present invention are that among the DL-integrated OOC obtained by chemical synthesis, when L-integrated OOC is converted to L-serine by hydrolysis etc. The purpose is to effectively utilize the remaining D by racemizing it.

〔発明の構成〕[Structure of the invention]

〈問題点を解決するための手段〉 本発明者らは、OOCのラセミ化法を種々検討した結果
、生化学的手法を用いるOOCのラセミ化法として本発
明を完成するに至った。
<Means for Solving the Problems> As a result of various studies on OOC racemization methods, the present inventors have completed the present invention as an OOC racemization method using biochemical techniques.

即ち、本発明は、OOCをラセミ化する能力を有する微
生物の培養液、菌体、菌体処理物、又はこれらからの精
製酵素、あるいは菌体または菌体処理物又は精製酵素の
固定化物をOOCに作用せしめて、 OOCをセラミ化
する方法に関する。
That is, the present invention provides a culture solution of a microorganism having the ability to racemize OOC, a bacterial cell, a bacterial cell-treated product, a purified enzyme therefrom, or a bacterial cell, a bacterial cell-treated product, or an immobilized product of a purified enzyme, as OOC. The present invention relates to a method for ceramizing OOC by acting on.

〈作用〉 本発明において用いるOOCをセラミ化せしめる能力を
有する微生物としては例えば ゾ1 リープス   パタタス   AJ 6011(Rhi
zopua    batatas )    FER
M−P 1?344クルブラリア グニキュラータ  
AJ 6325(Curvularim    gen
iculata  )   FKRM−P F?34j
エフェリス   エスピー   AJ 6338(Ep
h@lls     ep、   )    FERM
−P Fi’34にタラロマイセス  アーラネウス 
   AJ 7453(Talaromyeem  a
vellaneu+i )    FERM−P 83
47などがある。
<Function> Examples of microorganisms having the ability to ceramize OOC used in the present invention include Zo1 rhaps patatatus AJ 6011 (Rhi
zopua batas ) FER
M-P 1?344 Curvularia gniculata
AJ 6325 (Curvularim gen
iculata) FKRM-PF? 34j
Epheris SP AJ 6338 (Ep
h@lls ep, ) FERM
-P Talaromyces araneus in Fi'34
AJ 7453 (Talaromyem a
FERM-P 83
There are 47 etc.

また、上記以外の菌株でも、OOCをラセミ化する能力
を有する微生物であればすべて本発明の使用菌となり得
るものである。例えば、アルテルナリア ククメリナ 
AJ6262 、セファロセシウムエスピー AJ62
91 、フザリウム エスピー AJ 6340 。
In addition, any microorganism strain other than those mentioned above can be used in the present invention as long as it has the ability to racemize OOC. For example, Alternaria cucumelina
AJ6262, Cephalocesium SP AJ62
91, Fusarium sp. AJ 6340.

ベスタロティア エスピー AJ 6454 *フィジ
ウムエスビー AJ 6469 、ポトリティス レノ
タンスAJ 65661 )リコセシウム ロゼラム 
AJ 6574 。
Vestalotia sp. AJ 6454 *Physium sp. AJ 6469, Potrytis renotans AJ 65661) Lycocesium roserum
AJ6574.

アスペルギウス ギガンテウス AJ 7179 、ペ
ニシリウム シトリナム AJ 7014 tユーペニ
シウムパーネンス AJ 7430.7ニキシエラ レ
ティキュラータ AJ 7504 、グラジノスポラ 
ロンギスポーラAJ 7584 tコリネスポーラ メ
ロ−ニス AJ 6315゜スクレロチウム グルカニ
ラム AJ 6636 、 シ:2 )モマイセス ア
ルプス AJ 7572 、 ミクロアスクスロンギ日
ストリス AJ7609 、ポドスポーラセトラAJ 
7625 、モナスカス アンカ AJ7650などが
ある。
Aspergius giganteus AJ 7179, Penicillium citrinum AJ 7014 tEupenicium panens AJ 7430.7 Nixiera reticulata AJ 7504, Gradinospora
longispora AJ 7584 tCorynespora melonis AJ 6315゜Sclerotium glucanilum AJ 6636, 2) Momyces alpine AJ 7572, Microascus longii stris AJ7609, Podospora setra AJ
7625, Monascus Anchor AJ7650, etc.

本発明においてまずOOCをラセミ化する能力を有する
前記の如き微生物が培養される。培養法は通常の方法で
良い。
In the present invention, first, the above-mentioned microorganisms having the ability to racemize OOC are cultured. A conventional culture method may be used.

前述の如き微生物を培養するための培地には通常の栄養
培地を適宜使用すればよく、たとえば、炭素源としてグ
ルコース、シュクロース、グリセロール、糖蜜等の糖類
、酢酸等の有機酸、エタノール、メタノール等のアルコ
ール類など、窒素源として硫酸アンモニウム、塩化アン
モニウムなど、有機栄養源として、酵母エキス、ペプト
ン、肉エキス、コーン・ステイープリカーなど、無機イ
オンとして、マグネシウム、鉄、マンガン、カリウム、
ナトリウム、リン酸などのイオン、ビタミンとしてピリ
ドキシン、ピリドキシンリン酸などを用いることができ
る。また、培養にあたってOOCを少量培地に添加する
ことによって00Cのラセミ化能の高い培養物または、
菌体を取得できる場合もある。培養は常法によればよく
、たとえば培地の声は6〜9とし1本発明の菌株を接種
後、20〜40℃で1〜3日好気的に培養する。
As a medium for culturing the above-mentioned microorganisms, a normal nutrient medium may be used as appropriate. For example, as a carbon source, sugars such as glucose, sucrose, glycerol, and molasses, organic acids such as acetic acid, ethanol, methanol, etc. nitrogen sources such as ammonium sulfate and ammonium chloride; organic nutritional sources such as yeast extract, peptone, meat extract, and corn staple liquor; and inorganic ions such as magnesium, iron, manganese, potassium,
Ions such as sodium and phosphoric acid, and vitamins such as pyridoxine and pyridoxine phosphate can be used. In addition, by adding a small amount of OOC to the culture medium during culture, a culture with high racemization ability of 00C or
In some cases, bacterial cells can be obtained. Cultivation may be carried out by a conventional method; for example, after inoculating a strain of the present invention in a medium having a volume of 6 to 9, the culture is aerobically cultured at 20 to 40°C for 1 to 3 days.

本発明で用いる菌体処理物とは、上記のようにして得ら
れる培養物のうち、OOCをラセミ化する活性を有する
画分をいう。このような菌体処理物としては、培養液そ
のもの、培養液から菌体を分離した液、分離菌体、分離
菌体の分解物又は分解物の精製物などがある。これらの
菌体処理物はそのまま使用しても良く、凍結乾燥、アセ
トン乾燥などの処理を施しても良いし、固定化などの処
理を施しても良い。
The treated bacterial cell product used in the present invention refers to a fraction of the culture obtained as described above that has an activity of racemizing OOC. Such processed bacterial cells include the culture solution itself, a liquid obtained by separating the bacterial cells from the culture solution, isolated bacterial cells, a decomposed product of the isolated bacterial cells, or a purified product of the decomposed product. These bacterial cell-treated products may be used as they are, or may be subjected to treatments such as freeze-drying or acetone drying, or may be subjected to treatments such as immobilization.

本発明で用いる水性媒体中のOOC濃度はパッチ式、連
続式によっても異なるが、パッチ式では一般に水性媒質
中0.1〜30チ、好ましくは0.5〜10チ程度で連
続式では、これよりやや濃度を低下させた方が好ましい
The OOC concentration in the aqueous medium used in the present invention differs depending on whether it is a patch type or a continuous type, but in a patch type it is generally about 0.1 to 30 g, preferably about 0.5 to 10 g, and in a continuous type it is about 0.1 to 30 g. It is preferable to lower the concentration slightly.

反応は、普通、15〜60℃、好ましくは30℃〜40
℃附近で、pH−4〜10.好ましくは7附近で行なわ
れる。反応時間は、静置、攪拌、流下等の手段あるいは
画体処理物の形態、力価によって異なってくるので一様
ではないが、パッチ法では通常10分〜72時間程度で
ある。
The reaction is usually carried out at 15-60°C, preferably 30°C-40°C.
Around ℃, pH -4~10. Preferably, this is done around 7. The reaction time varies depending on the means of standing, stirring, flowing down, etc., and the form and potency of the object to be treated, so it is not uniform, but in the patch method it is usually about 10 minutes to 72 hours.

上記微生物を水溶性媒体中で培養しながら菌体と00C
と接触せしめて作用させる場合には00Cを含みかつ微
生物の生育に必要な炭素源、窒素源、無機イオン々どの
栄養源を含む水性媒体が用いられる。更に、ビタミン、
アミノ酸等の有機微量栄養素を添加すると望ましい結果
が得られる場合が多い。
While culturing the above microorganisms in an aqueous medium, the microorganisms and 00C
When the microorganism is brought into contact with the microorganism to cause its action, an aqueous medium containing 00C and nutrients such as a carbon source, nitrogen source, and inorganic ions necessary for the growth of microorganisms is used. Furthermore, vitamins
Addition of organic micronutrients such as amino acids often yields desirable results.

炭素源としては、グルコース、シュクロース等の炭水化
物、酢酸等の有機酸、アルコール類、その他が適宜使用
される。窒素源としては、アンモニアガス、アンモニア
水、アンモニウム塩、その他が用いられる。無機イオン
としては、マグネシウムイオン、燐酸イオン、カリイオ
ン、鉄イオンその他が必要に応じて適宜使用される。
As the carbon source, carbohydrates such as glucose and sucrose, organic acids such as acetic acid, alcohols, and others are used as appropriate. As the nitrogen source, ammonia gas, aqueous ammonia, ammonium salt, and others are used. As the inorganic ions, magnesium ions, phosphate ions, potassium ions, iron ions, and others are used as appropriate.

培養は、好気的条件下にpH4ないし8、温度25ない
し40℃の適当な範囲に制御しつつ行えば望ましい結果
が得られる。
Desired results can be obtained if the culture is carried out under aerobic conditions with pH 4 to 8 and temperature controlled within an appropriate range of 25 to 40°C.

これに対し上記微生物の菌体処理物を、OOCと接触せ
しめて作用せしめる場合には00Cと菌体処理物を含む
水性媒体を15℃ないし60℃の適当な温度に調節し−
を4ないし10に保ちつつ、暫時静置マたは攪拌すれば
よい。かくして10分ないし72時間も経過すれば水性
媒体中に多量のOOCのラセミ化物が生成蓄積される。
On the other hand, when the above-mentioned microbial cell-treated product is brought into contact with OOC to act, the aqueous medium containing OOC and the microbial cell-treated product is adjusted to an appropriate temperature of 15°C to 60°C.
It is sufficient to let it stand for a while or stir it while keeping the temperature between 4 and 10. Thus, after 10 minutes to 72 hours have elapsed, a large amount of racemized OOC is formed and accumulated in the aqueous medium.

本発明において酵素反応によりOOCがラセミ化したこ
とは、光学分割用樹脂を用いた液体クロマトグラフィー
により、D一体、L一体を定量することにより行なった
In the present invention, racemization of OOC due to enzymatic reaction was determined by quantifying D-unit and L-unit by liquid chromatography using an optical resolution resin.

ところで、OOC加水分解酵素生産Wi(特願昭59−
281339)のみを、D −000に作用させてもL
−セリンの生成は見られないが、以下の実施例に示す0
0Cのラセミ化能を有する微生物と、共存させることに
より、D −00Cから効率よくL−セリンが蓄積する
ことは次の実験例に示す通りである。
By the way, OOC hydrolase production Wi (patent application 1984-
Even if only 281339) acts on D-000, L
-No formation of serine is observed, but 0 as shown in the following example
As shown in the following experimental example, L-serine can be efficiently accumulated from D-00C by coexisting with a microorganism capable of racemizing 0C.

実験例 グリセロール2%、酵母エキス0.5係、ペプトン0.
5 %、NaC10,25%、DL−00CO,2%、
炭酸カルシウム4.0%(別殺菌)を含む培地(pH7
,0)を500m1容フラスコに501/入れ、120
℃。
Experimental example: 2% glycerol, 0.5% yeast extract, 0.5% peptone.
5%, NaC10,25%, DL-00CO,2%,
Medium containing 4.0% calcium carbonate (separately sterilized) (pH 7)
,0) into a 500ml flask, 120
℃.

15分間殺菌した。これにブイ蒔ン寒天培地で30℃に
て、24時間培養したタラロマイセス・アペラネウスF
ERM−P P、?41 の菌体を接種し、30℃。
Sterilized for 15 minutes. This was then cultured on Buoy's agar medium at 30°C for 24 hours.
ERM-P P,? 41 cells were inoculated and incubated at 30°C.

16時間培養したのち、菌体を遠心分離後洗浄し集め、
D−00C1%含むリン酸緩衝液(終末0.1M。
After culturing for 16 hours, the bacterial cells were centrifuged, washed, and collected.
Phosphate buffer containing 1% D-00C (0.1M final.

pi−17,0)に生菌体として5チに々るように加え
、30℃、48時間静置反応せしめた。反応終了後、こ
れに、同条件にて培養したシュードモナス・テストステ
ロー二ATCC17409を生菌体として5%になるよ
うに加え、更に30℃、48時間静置反応せしめた。反
応終了後、バイオアッセイにてL−セリンを定量したと
ころ142のL−セリンが生成してイタ。一方、シュー
ドモナスΦテストステローニATCC17409の生菌
体のみを、D −OCCに作用させても、L−セリンの
生成は全く見られなかった。
5 microorganisms were added as viable cells to 5 microorganisms (pi-17,0), and allowed to stand at 30° C. for 48 hours. After the reaction was completed, Pseudomonas testosteroni ATCC 17409, which had been cultured under the same conditions, was added to the mixture to give a concentration of 5% viable cells, and the mixture was left to react at 30° C. for 48 hours. After the reaction was completed, L-serine was quantified by bioassay, and 142 L-serines were produced. On the other hand, even when only viable cells of Pseudomonas Φtestosteroni ATCC 17409 were allowed to act on D-OCC, no production of L-serine was observed.

実施例1 実験例と同様の培地を用いて、第1表の微生物を接種し
、30℃、24時間培養したのち菌体を遠心分離後洗浄
し集め、D −00C1%を含む、酢酸緩衝液(終末0
.1 M 、終末pH4,0)あるいは、すン酸緩衝液
(終末0.1 M 、終末pl−17,0)あるいは、
トリス緩衝液(終末0.1 M 、終末p)48.5)
に生菌体として5チとなるように加え、30℃24時間
靜置反応装置めた。反応終了後、光学分割用樹脂を用い
た液体クロマトグラフィーで、生成したL−00Cを定
量し、第1表に示した。
Example 1 Using the same medium as in the experimental example, the microorganisms shown in Table 1 were inoculated, cultured at 30°C for 24 hours, and the bacterial bodies were centrifuged, washed and collected, and added to an acetate buffer containing 1% D-00C. (End 0
.. 1 M, final pH 4,0) or phosphate buffer (0.1 M final, final pl-17,0);
Tris buffer (0.1 M final, p final 48.5)
5 cells of viable cells were added to the tube, and the mixture was placed in a reactor at 30° C. for 24 hours. After the reaction was completed, the produced L-00C was quantified by liquid chromatography using an optical resolution resin, and the results are shown in Table 1.

第1表 声4.0又はpi−17,0又は−8,5にお
ける各棟菌株によるL −000の生成量 実施例2 実験例と同様の培地50ynl/ 500m/フラスコ
を用いて30℃で16時間培養したタラロマイセス・ア
ベラネウスFERM−Th’Oム養液中にD −00C
500■を含む水溶液101n/(pi47.0に調製
)を無菌的に投入し無菌的に培養液の−を7.0に調整
後更に10時間培養を行なった。培養中は2時間おきに
−を7.0になる様に無菌的に調製した。
Table 1 Amount of L-000 produced by each bacterial strain at pi-4.0 or pi-17,0 or -8,5 Example 2 16 at 30°C using the same medium 50ynl/500m/flask as in the experimental example D-00C in Talaromyces averaneus FERM-Th'Om nutrient solution cultured for hours.
After aseptically injecting 101 n/ml of an aqueous solution (prepared to a pi of 47.0) containing 500 μl and adjusting the - of the culture solution to 7.0, the culture was continued for a further 10 hours. During culturing, the cells were aseptically adjusted to -7.0 every 2 hours.

この培養液の一部を取り光学分割用樹脂を用いた液体ク
ロマトグラフィーを用いてL−00Cヲ定量したところ
139m9/diのL −00Cが生成していた。
When a portion of this culture solution was taken and L-00C was quantified using liquid chromatography using an optical resolution resin, 139 m9/di of L-00C was produced.

実施例3 実験例と同様の培地50 yR1/ 500mAフラス
コに、タラロマイセス・アペラネウスFERM−’i’
fl*mL、  30℃、16時間培養したのち、菌体
を遠心分離後洗浄し集め、L−又はD −00C1チを
含むリン酸緩衝液(終末0.1 M 、終末pi17.
0)に生菌体として5チとなるように加え30℃、18
時間靜直尺応せしめた。
Example 3 Talaromyces aperanaeus FERM-'i' was added to the same medium 50yR1/500mA flask as in the experimental example.
fl*mL, after culturing at 30°C for 16 hours, the bacterial cells were centrifuged, washed, collected, and diluted with a phosphate buffer containing L- or D-00C1 (0.1M final, pi17.
0) to a total of 5 cells as viable bacteria, and heated at 30℃ for 18
The time was calm and straight.

反応終了後、光学分割用樹脂を用いた液体クロマooc
を定量【−1第2表に示し友。
After the reaction is completed, liquid chromatography using optical resolution resin is performed.
Quantification of [-1] is shown in Table 2.

第2表 L−又はD−00Cを基質とした時のL−又は
D −00Cの生成量 実施例4 実験例と同様の培地50d1500mフラスコを用いて
30℃で16時間培養したタラロマイセス・アペラネウ
スFERM−潔’i体を生理食塩水に20117diに
なる様に懸濁した菌液5−に4チアルギン酸ナトリウム
溶液5−を加え混合したのち、15117dtの塩化カ
ルシウム溶液に、この混合液を徐々に滴下し、ビーズ状
の固定化菌体を作成した。この固定化物全量をD −0
001%を含むリン酸緩衝液(終末0.1M 、終末p
i−17,0)に投入し30℃、16時間反応させた。
Table 2 Amount of L- or D-00C produced when L- or D-00C is used as a substrate Example 4 Talaromyces aperaneus FERM- cultivated at 30°C for 16 hours using the same medium 50d and 1500m flask as in the experimental example. After adding and mixing 4-sodium thyalginate solution 5- to a bacterial solution 5- in which a bacterial strain was suspended in physiological saline to a concentration of 20117 dt, this mixed solution was gradually added dropwise to a calcium chloride solution of 15117 dt. , we created bead-shaped immobilized bacterial cells. The total amount of this immobilized material is D −0
Phosphate buffer containing 0.01% (0.1 M final, p
i-17,0) and reacted at 30°C for 16 hours.

この結果D −00Cはラセミ化され、反応液中には1
22m9/dlのL−OOCが生成していた。
As a result, D-00C was racemized, and 1
22 m9/dl of L-OOC was generated.

出 願 人  味の素株式会社 手続補正用 昭和60年8り〃旧 1、事件の表示 昭和60年特許願第157153号 2、発明の名称 2−オキソ−オキ量ナシリジンー4−カルボン酸のうt
ζミ化法3、補正をする者 事件との関係  特許出願人 住所   東京都中央区京橋−1m 5番8月5、補正
により増加する発明の数   なし6、補正の対象  
 明細書の発明の詳細な説明の欄7、補正の内容 (1)明細書第2頁11行目「収率が低くく、」を1収
率が低く、」と訂正する。
Applicant Ajinomoto Co., Ltd. Procedural Amendment 1985 August 1, Case Indication 1985 Patent Application No. 157153 2, Title of Invention 2-Oxo-Ox Amount of Nasiridine-4-Carboxylic Acid
Zeta-minimization method 3, relationship with the case of the person making the amendment Patent applicant address No. 5, Kyobashi-1m, Chuo-ku, Tokyo August 5, Number of inventions increased by amendment None 6, Subject of amendment
Column 7 of Detailed Description of the Invention in the Specification, Contents of Amendment (1) On page 2, line 11 of the specification, ``The yield is low,'' is corrected to ``1 The yield is low.''

Claims (1)

【特許請求の範囲】[Claims] 光学活性な2−オキソ−オキサゾリジン−4−カルボン
酸又はその塩をラセミ化する能力を有するリゾプス属、
クルブラリア属、エフェリス属、タラロマイセス属に属
する微生物の処理物を、光学活性な2−オキソ−オキサ
ゾリジン−4−カルボン酸又は、その塩に作用せしめて
光学活性な2−オキソ−オキサゾリジン−4−カルボン
酸をラセミ化せしめることを特徴とする2−オキソ−オ
キサゾリジン−4−カルボン酸のラセミ化法。
Rhizopus having the ability to racemize optically active 2-oxo-oxazolidine-4-carboxylic acid or a salt thereof,
Optically active 2-oxo-oxazolidine-4-carboxylic acid is produced by reacting a processed product of microorganisms belonging to the genus Curvularia, Epheris, and Talaromyces with optically active 2-oxo-oxazolidine-4-carboxylic acid or a salt thereof. A method for racemizing 2-oxo-oxazolidine-4-carboxylic acid, which comprises racemizing 2-oxo-oxazolidine-4-carboxylic acid.
JP15715385A 1984-12-27 1985-07-17 Racemization of 2-oxo-oxazolidine-4-carboxylic acid Pending JPS6219095A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP15715385A JPS6219095A (en) 1985-07-17 1985-07-17 Racemization of 2-oxo-oxazolidine-4-carboxylic acid
DE8585309455T DE3580463D1 (en) 1984-12-27 1985-12-23 METHOD FOR PRODUCING L-SERINE.
EP85309455A EP0187525B1 (en) 1984-12-27 1985-12-23 Process for producing l-serine
US07/348,112 US5036004A (en) 1984-12-27 1989-05-05 Process for producing L-serine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15715385A JPS6219095A (en) 1985-07-17 1985-07-17 Racemization of 2-oxo-oxazolidine-4-carboxylic acid

Publications (1)

Publication Number Publication Date
JPS6219095A true JPS6219095A (en) 1987-01-27

Family

ID=15643337

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15715385A Pending JPS6219095A (en) 1984-12-27 1985-07-17 Racemization of 2-oxo-oxazolidine-4-carboxylic acid

Country Status (1)

Country Link
JP (1) JPS6219095A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60137135A (en) * 1984-11-30 1985-07-20 Hitachi Denshi Ltd Control system for transmission electric power

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60137135A (en) * 1984-11-30 1985-07-20 Hitachi Denshi Ltd Control system for transmission electric power
JPS6219095B2 (en) * 1984-11-30 1987-04-27 Hitachi Electronics

Similar Documents

Publication Publication Date Title
US5108917A (en) Process for the preparation of ibuprofen
JP2950896B2 (en) Method for producing D-α-phenylglycine
JP3951008B2 (en) Capsaicin decomposing / synthesizing enzyme and production method thereof
US5300430A (en) Biocatalytic process for the production of L-(-)-carnitine from crotonobetaine and strains of proteus for use in said process
AU674945B2 (en) Enantioselective hydrolysis of ketoprofen esters by (beauveria bassiana) and enzymes derived therefrom
JPS6219095A (en) Racemization of 2-oxo-oxazolidine-4-carboxylic acid
US2443919A (en) Fermentation process for production of alpha-ketoglutaric acid
JPS58201992A (en) Preparation of beta-substituted propionic acid or amide thereof by microorganism
JP3030916B2 (en) Method for producing β-glucooligosaccharide
JPH0591895A (en) Method for producing D-serine
JPH0424992B2 (en)
US4334021A (en) Process for producing coproporphyrin III
JP3917723B2 (en) Lactone hydrolase and process for producing the same
US2953499A (en) Process for producing l-glutamic acid from hardly soluble amino-acid
US4208481A (en) Use of phenylalkanes as precursors in benzylpenicillin fermentation
JPS63157990A (en) Production of l-alpha-methylphenylalanines
JP2899071B2 (en) Method for producing L-α-alanine
JPS61257196A (en) Racemization of 2-oxo-oxazolidine-4-carboxylic acid
SU553283A1 (en) Alcohol dehydrogenase production method
JP3659123B2 (en) Method for optical resolution of 4-halogeno-3-alkanoyloxybutyronitrile
JPS61257194A (en) Production of l-serine
JPH0353914B2 (en)
JPH0515394A (en) Production of optically active (s)-3-phenyl-1,3propanediol
JPS61152292A (en) Production of l-serine
JPH08154692A (en) Production of d-2-aminobutyric acid